North America Animal Sedative Market Size, Share & Trends Analysis Report By Route of Administration, By Animal Type, By Drug Class, By End Use (Hospitals and Specialty Centers), By Application (Surgical, Diagnostic, and Others), By Country and Growth For

North America Animal Sedative Market Size, Share & Trends Analysis Report By Route of Administration, By Animal Type, By Drug Class, By End Use (Hospitals and Specialty Centers), By Application (Surgical, Diagnostic, and Others), By Country and Growth Forecast, 2024 - 2031

The North America Animal Sedative Market would witness market growth of 5.2% CAGR during the forecast period (2024-2031).

The US market dominated the North America Animal Sedative Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $130,740.2 Thousands by 2031. The Canada market is experiencing a CAGR of 7.2% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 7.7% during (2024 - 2031).

Animal sedatives are pharmaceutical drugs used to induce sedation or calmness in animals for various medical procedures, handling, or behavioral management. These medications act on the central nervous system, producing effects such as relaxation, reduced anxiety, muscle relaxation, and, in some cases, sleepiness. Veterinarians commonly administer them to facilitate safe and stress-free handling of animals during examinations, surgeries, diagnostic procedures, and transportation.

In addition, animal sedatives are essential pharmaceuticals used across diverse sectors of veterinary care to manage animals' behavior and physical responses during medical procedures, examinations, and handling. Sedatives are commonly used in veterinary clinics and hospitals to calm pets during routine examinations, vaccinations, dental cleanings, and minor surgical procedures.

As the pet population in Canada grows, so does the need for veterinary care, including procedures that may require sedation. According to the Canadian Animal Health Institute, the number of dogs and cats in Canada increased between 2020 and 2022, rising from 8.1 million to 8.5 million for cats and from 7.7 million to 7.9 million for dogs. With more Canadians owning pets, there is a corresponding expansion in the number of veterinary clinics, hospitals, and practices across the country. This expansion increases the availability of veterinary services and drives the demand for pharmaceutical products, including sedatives, used in these facilities. Also, 3% rise from 58% in 2020 to 61% in 2022 in the number of cats reported to have visited a vet in the previous 12 months. Hence, increasing clinical visits and the rising population of pets in the region are driving the market's growth.

Based on Route of Administration, the market is segmented into Parenteral and Oral. Based on Animal Type, the market is segmented into Dogs, Cats, Horses, and Others. Based on Drug Class, the market is segmented into Alpha-2 Adrenergic Receptor Agonists, Phenothiazines, Benzodiazepines, Butyrophenones, and Others. Based on End Use, the market is segmented into Hospitals and Specialty Centers. Based on Application, the market is segmented into Surgical, Diagnostic, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

• Zoetis, Inc.
• Virbac
• Dechra Pharmaceuticals PLC
• Merck & Co., Inc.
• Bimeda, Inc.
• Ouro Fino Saude Animal Participacoes S.A.
• vetcare. fi.
• Chanelle Pharma (Exponent)
• Randlab Australia Pty Ltd.
• Troy Laboratories Pty Ltd.

North America Animal Sedative Market Report Segmentation

By Route of Administration

• Parenteral
• Oral

By Animal Type

• Dogs
• Cats
• Horses
• Others

By Drug Class

• Alpha-2 Adrenergic Receptor Agonists
• Phenothiazines
• Benzodiazepines
• Butyrophenones
• Others

By End Use

• Hospitals
• Specialty Centers

By Application

• Surgical
• Diagnostic
• Others

By Country

• US
• Canada
• Mexico
• Rest of North America